Intellectual property and medical devices sit at the heart of life sciences disputes, where cutting-edge technology meets complex contractual frameworks. This panel will explore how arbitration is being used to resolve IP and device-related issues in high-value transactions. From licensing and patent rights to regulatory hurdles and cross-border enforcement, discover the trends shaping arbitration in this critical sector.